ARCT-165(Arcturus Therapeutics)

N/A

Report date: 2026/05/13 11:17:46

Base Information

Drug NameARCT-165(Arcturus Therapeutics)

Drug Alias NameARCT-165

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSingaporeSouth Africa

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesArcturus Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A